Car Bruce Insider Trades

Insider Trading History

Track insider trading activity for Car Bruce. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $2.61M 175,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 175,000 shares
$11.52
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $142k 9,500 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.2k 4,750 shares
$9.93
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $115k 7,715 shares
Last Trade
Jan 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$23.6k 2,381 shares
$9.93
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $151k 10,096 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.2k 4,750 shares
$9.93
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $71.7k 4,802 shares
Last Trade
Jan 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$90.1k 2,331 shares
$38.64
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $1.67M 112,000 shares
Last Trade
Jan 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.33M 112,000 shares
$38.64
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $213k 14,250 shares
Last Trade
Jan 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 4,750 shares
$38.64
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $107k 7,133 shares
Last Trade
Jan 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 4,750 shares
$38.64
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $448k 30,000 shares
Last Trade
Jun 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.01M 30,000 shares
$33.58
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $1.44M 96,250 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.04M 96,250 shares
$41.93
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $1.18M 78,750 shares
Last Trade
Nov 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.32M 78,750 shares
$29.49
$14.94
Biohaven
Biohaven BHVN
Chief Scientific Officer
Holding Value $4.48M 300,000 shares
Last Trade
Oct 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.5M 300,000 shares
$151.80
$14.94
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.64M 41,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 52,500 shares
$32.20
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $669k 16,752 shares
Last Trade
Feb 22, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.4k 2,041 shares
$29.08
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $750k 18,793 shares
Last Trade
Feb 18, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 6,874 shares
$29.42
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $274k 6,874 shares
Last Trade
Feb 18, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 6,874 shares
$29.42
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $476k 11,919 shares
Last Trade
Feb 10, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.7k 1,073 shares
$31.43
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $519k 12,992 shares
Last Trade
Feb 10, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 3,667 shares
$31.05
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $293k 7,333 shares
Last Trade
Feb 10, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 3,667 shares
$31.05
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $137k 3,437 shares
Last Trade
Jan 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$115k 3,437 shares
$33.36
$39.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up